Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma
Open Access
- 31 July 2008
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 14 (7), 795-798
- https://doi.org/10.1016/j.bbmt.2008.04.008
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Compromised stem cell mobilization following induction therapy with lenalidomide in myelomaLeukemia, 2008
- Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapyBritish Journal of Haematology, 2007
- High-dose Therapy with Single Autologous Transplantation versus Chemotherapy for Newly Diagnosed Multiple Myeloma: A Systematic Review and Meta-analysis of Randomized Controlled TrialsTransplantation and Cellular Therapy, 2007
- Stem cell transplant for first relapse from the multiple myeloma research foundation.2006
- Long‐term outcome results of the first tandem autotransplant trial for multiple myelomaBritish Journal of Haematology, 2006
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Cyclophosphamide Mobilization Does Not Improve Outcome in Patients Receiving Stem Cell Transplantation for Multiple MyelomaClinical Lymphoma Myeloma and Leukemia, 2006
- Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myelomaBlood, 2005
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.Journal of Clinical Oncology, 1998